Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-15

Clinical Trial Update: Milrinone Versus Placebo in Patients With Septic Shock [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing milrinone to placebo in patients with septic shock, focusing on cardiac output.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Milrinone (milrinone)

Snippet

Sponsor: Mahidol University | Conditions: Septic Shock, Cardiac Output | Phase 2 | Status: UNKNOWN